WELL Health Technologies, a digital healthcare company focused on improving health outcomes through technology and empowering healthcare providers globally, is pleased to announce the launch of a new weight care vertical by its majority-owned subsidiary, Wisp, the largest dedicated women’s telehealth provider in the US. With Wisp now serving over 1.2 million patients, this expansion represents a pivotal step forward in addressing critical health needs related to hormonal imbalances and weight management for women.
Through this launch, Wisp introduces personalised, online consultations with access to four weight care solutions, including GLP-1 medications, to support women struggling with hormonal conditions such as perimenopause, menopause, Polycystic Ovary Syndrome (PCOS) and endometriosis. Additionally, Wisp debuts its first-ever exclusive over-the-counter weight care capsules, designed to promote women’s metabolic health.
“Wisp is committed to providing sustainable support for women’s weight loss journeys, addressing a critical yet overlooked aspect of women’s health,” said Monica Cepak, CEO of Wisp. “As the dialogue around obesity evolves, we recognise that underlying conditions — especially hormonal imbalances linked to perimenopause and menopause — remain under-researched, underdiagnosed and undertreated. With these new offerings, we’re proud to continue expanding access to comprehensive care, offering tailored solutions for every woman and every condition at every price point.”